Humanin Dosing & Reconstitution Guide

Humanin, particularly the S14G variant, has been studied for its potential roles in metabolic regulation and mitochondrial function. In research settings, Humanin is typically administered via subcutaneous or intraperitoneal routes. While there is no established dosing regimen for human subjects, animal studies provide some insights into effective dosing ranges. Specifically, research involving mice has demonstrated that doses ranging from 0.2 to 4 mg/kg administered intraperitoneally can elicit biological effects, with the HNG variant being active at nanomolar concentrations. It is important for researchers to consider these findings within the context of their experimental design and goals, as individual study parameters may influence the appropriateness of these dose ranges.

Proper storage of Humanin is essential to maintain its stability and integrity for research applications. When lyophilized, Humanin should be stored at -20 °C (-4 °F), which helps preserve its structure and biological activity. Once reconstituted, the peptide should be kept at a temperature range of 2-8 °C (35.6-46.4 °F) to prevent degradation. It is important to note that the shelf life of reconstituted Humanin is limited to 14 days. Researchers should ensure that storage conditions are strictly adhered to in order to avoid compromising the quality of the peptide prior to use in experiments.

While Humanin is an endogenous peptide naturally found in human circulation, there is currently no formal safety data available from clinical trials involving human subjects. However, animal studies have not reported any adverse effects at the doses tested, suggesting a favorable safety profile in those models. Researchers should remain cautious, particularly in specific populations. For instance, individuals with active cancer may be contraindicated due to Humanin's anti-apoptotic properties, which could inadvertently protect tumor cells. Additionally, there is insufficient data regarding the use of Humanin in pregnant or breastfeeding individuals, necessitating careful consideration in these contexts.